JMP Securities Initiates Coverage On Sana Biotechnology With Market Outperform Rating, Announces Price Target of $9
JMP Securities Initiates Coverage On Sana Biotechnology With Market Outperform Rating, Announces Price Target of $9
JMP Securities以市场跑赢大盘的评级开始报道Sana Biotechnology,宣布目标股价为9美元
JMP Securities analyst Reni Benjamin initiates coverage on Sana Biotechnology (NASDAQ:SANA) with a Market Outperform rating and announces Price Target of $9.
JMP证券分析师Reni Benjamin对Sana Biotech(纳斯达克:SANA)进行了报道,评级为市场表现优于大盘,并宣布目标价为9美元。